Global Genomics Sorenson Genomics operates as a world-leading human genomics and DNA sequencing service provider with global reach, presenting opportunities to upsell high-throughput sequencing, validated genotyping, and international accredited testing capabilities to multinational labs and clinics.

Mid-market Focus With 51-200 employees and revenue in the 10-25 million range, target mid-sized biotech firms and regional clinics that require scalable sequencing services, compliance-driven testing, and rapid turnaround for personalized medicine or forensic genomics projects.

Accredited Advantage Independent and internationally accredited laboratory status can be leveraged to pursue partnerships for contract testing, data reliability, and custody of high-stakes genomic data, appealing to customers needing stringent quality and regulatory compliance.

R&D Portfolio A strong Genomics R&D pipeline suggests cross-sell opportunities for novel sequencing methods, expanded genotyping panels, and custom assay development for pharmaceutical collaborations, clinical research, and population genomics studies.

Competitive Positioning Position Sorenson as a cost-effective, high-quality alternative to larger players by emphasizing flexibility, personalized support, and global service coverage to win projects from mid-tier customers considering price-to-value trade-offs against larger vendors.